Solaris

Soliris (eculizumab) Approved by FDA for All Patients with Atypical Hemolytic Uremic Syndrome (aHUS)

 
 
- First and Only Approved Treatment for Children and Adults Suffering with aHUS, an Ultra-Rare, Life-Threatening Disease –
- Conference Call Scheduled for Monday, September 26, 2011 at 10:00am Eastern -

No votes yet
Syndicate content